Table 3

Variability analysis results in diabetics

	BMI			LDL-cholesterol
	Estimate	95% CI	P value	Estimate	95% CI	P value
Intercept	24.35	(24.19 to 24.51)	<0.001	101.25	(99.58 to 102.88)	<0.001
	2.50	(2.39 to 2.62)	<0.001	23.16	(21.93 to 24.48)	<0.001
Gamma rate	9.58	(8.35 to 10.95)	<0.001	0.32	(0.27 to 0.38)	<0.001
Gamma shape	7.89	(6.92 to 8.98)	<0.001	7.43	(6.36 to 8.67)	<0.001
CVD
Intercept	−0.65	(−0.94 to 0.34)	<0.001	−0.56	(−0.85 to −0.26)	<0.001
Sex	0.03	(−0.03 to 0.09)	0.326	0.00	(−0.05 to 0.06)	0.905
Age	0.01	(0.01 to 0.01)	<0.001	0.01	(0.01 to 0.01)	<0.001
Smoking	0.07	(0.01 to 0.12)	0.012	0.05	(0.01 to 0.10)	0.028
Exercise, moderate	0.00	(−0.06 to 0.06)	0.958	0.00	(−0.06 to 0.05)	0.910
Exercise, hard	−0.12	(−0.18 to −0.06)	<0.001	−0.06	(−0.12 to −0.01)	0.031
SBP	0.00	(0.00 to 0.00)	0.707	0.00	(0.00 to 0.00)	0.841
Total cholesterol	0.00	(0.00 to 0.00)	<0.001	0.00	(0.00 to 0.00)	<0.001
vBMI	−0.05	(−0.14 to 0.04)	0.273
mBMI	0.01	(0.00 to 0.01)	0.194
vLDL-cholesterol				0.00	(0.00 to 0.00)	0.509
mLDL-cholesterol				0.00	(0.00 to 0.00)	0.252
Residual	0.35	(0.33 to 0.36)	<0.001	0.31	(0.29 to 0.32)	<0.001

The p value is for testing of variables that may affect the occurrence of CVD. It is desirable to interpret the significance level of statistical decision-making down to 2.5% by Bonferroni’s correction to control family-wise type 1 error rate.
BMI, body mass index; CVD, cardiovascular disease; LDL, low-density lipoprotein; mBMI, average BMI; mLDL-cholesterol, average LDL-cholesterol; SBP, systolic blood pressure; vBMI, variability of BMI; vLDL-cholesterol, variability of LDL-cholesterol.